| Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies JS Mandelblatt, NK Stout, CB Schechter, JJ Van Den Broek, DL Miglioretti, ... Annals of internal medicine 164 (4), 215-225, 2016 | 306 | 2016 |
| Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012 SK Plevritis, D Munoz, AW Kurian, NK Stout, O Alagoz, AM Near, SJ Lee, ... Jama 319 (2), 154-164, 2018 | 302 | 2018 |
| Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality D Munoz, AM Near, NT Van Ravesteyn, SJ Lee, CB Schechter, O Alagoz, ... Journal of the National Cancer Institute 106 (11), dju289, 2014 | 182 | 2014 |
| Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling O Alagoz, KP Lowry, AW Kurian, JS Mandelblatt, MA Ergun, H Huang, ... JNCI: Journal of the National Cancer Institute 113 (11), 1484-1494, 2021 | 128 | 2021 |
| Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes A Trentham-Dietz, K Kerlikowske, NK Stout, DL Miglioretti, CB Schechter, ... Annals of internal medicine 165 (10), 700-712, 2016 | 125 | 2016 |
| The University of Wisconsin breast cancer epidemiology simulation model: an update O Alagoz, MA Ergun, M Cevik, BL Sprague, DG Fryback, RE Gangnon, ... Medical decision making 38 (1_suppl), 99S-111S, 2018 | 60 | 2018 |
| Effect of time to diagnostic testing for breast, cervical, and colorectal cancer screening abnormalities on screening efficacy: a modeling study CM Rutter, JJ Kim, RGS Meester, BL Sprague, EA Burger, AG Zauber, ... Cancer Epidemiology, Biomarkers & Prevention 27 (2), 158-164, 2018 | 46 | 2018 |
| Using active learning for speeding up calibration in simulation models M Cevik, MA Ergun, NK Stout, A Trentham-Dietz, M Craven, O Alagoz Medical Decision Making 36 (5), 581-593, 2016 | 27 | 2016 |
| Benefits and harms of mammography screening for women with Down syndrome: a collaborative modeling study O Alagoz, A Hajjar, S Chootipongchaivat, NT van Ravesteyn, JM Yeh, ... Journal of general internal medicine 34, 2374-2381, 2019 | 15 | 2019 |
| Comparing CISNET breast cancer incidence and mortality predictions to observed clinical trial results of mammography screening from ages 40 to 49 JJ van den Broek, NT van Ravesteyn, JS Mandelblatt, H Huang, ... Medical Decision Making 38 (1_suppl), 140S-150S, 2018 | 13 | 2018 |
| Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer A Hajjar, MA Ergun, O Alagoz, M Rampurwala PloS one 14 (6), e0217778, 2019 | 11 | 2019 |
| Using collaborative simulation modeling to develop a web-based tool to support policy-level decision making about breast cancer screening initiation age ES Burnside, SJ Lee, C Bennette, AM Near, O Alagoz, H Huang, ... MDM policy & practice 2 (2), 2381468317717982, 2017 | 9 | 2017 |
| Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening A Trentham-Dietz, MA Ergun, O Alagoz, NK Stout, RE Gangnon, ... Breast cancer research and treatment 168, 229-239, 2018 | 5 | 2018 |
| Optimal breast cancer risk reduction policies tailored to personal risk level MA Ergun, A Hajjar, O Alagoz, M Rampurwala Health care management science 25 (3), 363-388, 2022 | | 2022 |
| Prediction Modeling N Alkan, Y Turgut, E Ari, S Ata, MY Ulukus, MA Ergun, OF Beyca Business Analytics for Professionals, 49-112, 2022 | | 2022 |
| Manufacturing Analytics N Alkan, D Oruc, A Gulbiter, MA Ergun Business Analytics for Professionals, 457-481, 2022 | | 2022 |
| Impact of disruptions in breast cancer control due to the COVID-19 pandemic on breast cancer mortality in the United States: Estimates from collaborative simulation modeling. O Alagoz, KP Lowry, AW Kurian, JS Mandelblatt, MA Ergun, H Huang, ... Journal of Clinical Oncology 39 (15_suppl), 6562-6562, 2021 | | 2021 |
